Recently cleared products will be highlighted at workshops, product demonstrations, events, and posters
AUSTIN, Texas - Luminex Corporation (NASDAQ: LMNX) today announced that it will be featuring the newly FDA-cleared ARIES® System and recently CE-marked NxTAG® Respiratory Pathogen Panel at the Association for Molecular Pathology (AMP) Annual Meeting occurring November 5 to 7, 2015 in Austin, Texas.
ARIES® is a sample to answer system crafted to increase laboratory efficiency, produce accurate results, and fit seamlessly into today's lean laboratory environment. The ARIES® System uses internal barcode scanning and other advanced features to minimize operator errors. Two independent modules each support from one to six cassettes, allowing for both STAT and Batch testing. IVD and MultiCode® Analyte Specific Reagents can be run simultaneously when using a common Universal Assay Protocol. An integrated touchscreen PC eliminates the need for a separate computer, stand-alone keyboard, and mouse; thus maximizing valuable bench space.
ARIES at AMP
-- Workshop: "Welcome to the New Way to Work: ARIES®, the Next Generation
of Sample to Answer Testing," on Wednesday, November 4, 2015 at 9 am in
Room 12B, Level 4. Stephen Young, PhD, D(ABMM), Scientific
Director-Infectious Disease, TriCore Reference Laboratories, will
present performance characteristics of ARIES® HSV 12 Assay based on
the clinical trial data generated at TriCore and share the ARIES work
experience at his laboratory.
-- Poster: "Improved Laboratory Workflow with ARIES®--A Time and Motion
Study" (S. Dunbar/Luminex).
-- ARIES® Introduction: Thursday, November 5 at 3 pm at Booth #911:
Luminex will officially mark the launch of ARIES® with remarks by
customers in the early access program.
NxTAG Respiratory Pathogen Panel is CE-marked in Europe, and available for Research Use Only (RUO) in the U.S. NxTAG Respiratory Pathogen Panel is an assay that detects relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila. The panel is the only respiratory assay that enables laboratories to easily and simultaneously detect these respiratory pathogens in a single, closed tube system and in a format that scales to accommodate changes in throughput needed to respond to seasonal changes in demand, especially during flu season. NxTAG Respiratory Pathogen Panel requires only minutes of hands-on time with no upstream reagent preparation. The innovative tube strip design offers laboratories the flexibility to process a single sample or up to 96 samples per run, without wasting consumables or reagents. Total turnaround time is only about three hours for 96 samples (excluding extraction).
NxTAG at AMP
-- Workshop:"NxTAG Respiratory Pathogen Panel (RUO)*--The New Paradigm in
Molecular Respiratory Disease Testing," Wednesday, November 4, 2015 at 3
pm in Room 12B, Level 4. Dr. Catherine Moore from Public Health Wales
will describe a prospective study to determine baseline respiratory
pathogen levels in sudden death cases. In combination with culture and
histology, the NxTAG Respiratory Pathogen Panel (RUO) revealed that
respiratory viruses are frequently detected in the respiratory tracts of
these individuals, and especially in infants. Dr. Arundhati Rao from
Scott White Memorial Hospital will present results of the NxTAG
clinical study conducted at her laboratory and share some insights from
a time and motion study comparing NxTAG to other molecular respiratory
-- Posters: "Automation of the Luminex NxTAG Respiratory Pathogen Panel
(RUO)" (M. Phillips/Luminex); "Assessment of a High Throughput Next
Generation Multiplex Respiratory Pathogen Panel" (J.H. Chen/Queen Mary
Hospital, Hong Kong; LMD); "Workflow Evaluation of the Luminex NxTAG
Respiratory Pathogen Panel (RUO)" (K. Post/IU Health).
AMP Events Sponsored by Luminex
-- International Showcase Event, Wednesday, November 4, 2015 at 7 pm. This
event will feature selected case study presentations on international
collaborations with members outside the U.S. and updates on the
initiatives of the International Affairs Committee and AMP's
-- Science Educator Workshop, Wednesday, November 4, 2015 from 7:30 am-3:35
pm. AMP will be hosting a complimentary workshop for Austin area
educators at local high schools and colleges. The goal is to introduce
molecular diagnostics as a valuable and in-demand field of study to
these science teachers.
About Luminex Corporation
Luminex is committed to applying its passion for innovation toward creating breakthrough solutions to improve health and advance science. The company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture multi-analyte platform, MultiCode® real-time polymerase chain reaction (PCR), and multiplex PCR-based technologies, that deliver cost-effective rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories, as well as major pharmaceutical, diagnostic, biotechnology and life science companies. Luminex is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, biodefense research, and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.
Luminex Media Contact
Christine Valle, 512-219-8020
Sr. Manager, Global Marketing
Additional Media Contact
Nicole Litchfield, 415-793-6468
*For Research Use Only. Not for use in diagnostic procedures.
Web Site: http://www.luminexcorp.com